PPP2R5D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.012600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.246400E-01
Normal-vs-Stage2
8.206400E-01
Normal-vs-Stage3
2.764200E-01
Normal-vs-Stage4
6.485600E-01
Stage1-vs-Stage2
2.990800E-01
Stage1-vs-Stage3
7.324000E-01
Stage1-vs-Stage4
1.405420E-01
Stage2-vs-Stage3
2.147800E-01
Stage2-vs-Stage4
4.398800E-01
Stage3-vs-Stage4
2.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.883200E-01
Normal-vs-AfricanAmerican
7.417600E-01
Normal-vs-Asian
8.182000E-01
Caucasian-vs-AfricanAmerican
9.903000E-01
Caucasian-vs-Asian
9.795400E-01
AfricanAmerican-vs-Asian
9.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.420600E-01
Normal-vs-Female
7.445400E-01
Male-vs-Female
6.505200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.020500E-02
Normal-vs-Age(41-60Yrs)
8.614600E-01
Normal-vs-Age(61-80Yrs)
6.450600E-01
Normal-vs-Age(81-100Yrs)
9.421600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.830000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.800800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.068400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.596300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.429400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.019000E-01
Normal-vs-Daily Drinker
4.239400E-01
Normal-vs-Weekly Drinker
4.054200E-01
Normal-vs-Occasional Drinker
7.813200E-01
Normal-vs-Social Drinker
7.071800E-01
Non Drinker-vs-Daily Drinker
7.021200E-01
Non Drinker-vs-Weekly Drinker
5.456500E-02
Non Drinker-vs-Occasional Drinker
1.451640E-01
Non Drinker-vs-Social Drinker
4.231600E-01
Daily Drinker-vs-Weekly Drinker
4.324400E-02
Daily Drinker-vs-Occasional Drinker
1.074170E-01
Daily Drinker-vs-Social Drinker
2.780800E-01
Weekly Drinker-vs-Occasional Drinker
6.571400E-01
Weekly Drinker-vs-Social Drinker
2.228200E-01
Occasional Drinker-vs-Social Drinker
4.732600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.675000E-01
Normal-vs-Grade 2
9.196800E-01
Normal-vs-Grade 3
9.469000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.151670E-02
Grade 1-vs-Grade 3
9.740400E-02
Grade 1-vs-Grade 4
9.675000E-01
Grade 2-vs-Grade 3
4.555200E-01
Grade 2-vs-Grade 4
9.196800E-01
Grade 3-vs-Grade 4
9.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.835000E-01
Normal-vs-NonDiabetic
8.440200E-01
Diabetic-vs-NonDiabetic
2.297200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.177800E-01
Normal-vs-NoPancreatitis
7.642000E-01
Pancreatitis-vs-NoPancreatitis
6.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.072200E-01
Normal-vs-N1
8.192800E-01
N0-vs-N1
8.385600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.134200E-01
Normal-vs-TP53-NonMutant
9.606200E-01
TP53-Mutant-vs-TP53-NonMutant
1.749350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
